Pleural infection: changing bacteriology and its implications

T Lisboa, GW Waterer, YCG Lee - Respirology, 2011‏ - Wiley Online Library
The incidence of pleural infection continues to rise worldwide. Identifying the causative
organism (s) is important to guide antimicrobial therapy. The bacteriology of pleural infection …

Pneumococcal vaccines for children: a global public health priority

LF Pittet, KM Posfay‐Barbe - Clinical Microbiology and …, 2012‏ - Wiley Online Library
Clin Microbiol Infect 2012; 18 (Suppl. 5): 25–36 Abstract Pneumococcal conjugated
vaccines have been recommended in children for over a decade in many countries …

Molecular epidemiology of Streptococcus pneumoniae isolates causing invasive and noninvasive infection in Ethiopia

B Sharew, F Moges, G Yismaw, A Mihret, TA Lobie… - Scientific Reports, 2024‏ - nature.com
Streptococcus pneumoniae, a medically important opportunistic bacterial pathogen of the
upper respiratory tract, is a major public health concern, causing a wide range of …

Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age-and serotype-dependent incidence of invasive …

J Picazo, J Ruiz-Contreras… - Clinical and Vaccine …, 2013‏ - journals.asm.org
ABSTRACT In Madrid, Spain, the 13-valent pneumococcal conjugate vaccine (PCV13)
replaced PCV7 in the pediatric universal vaccination calendar in June 2010. A prospective …

Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in …

J Picazo, J Ruiz-Contreras… - The Pediatric …, 2013‏ - journals.lww.com
Background: Differences in invasive pneumococcal disease (IPD) in children are expected
after a change from 7-valent pneumococcal conjugate vaccine (PCV7) to 13-valent …

Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and …

J Picazo, J Ruiz-Contreras, J Casado-Flores… - PLoS …, 2017‏ - journals.plos.org
In the Community of Madrid, the 13-valent pneumococcal conjugate vaccine (PCV13)
replaced the 7-valent (PCV7) in the fully government-funded Regional Immunization …

Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The …

JJ Picazo, J Ruiz-Contreras, J Casado-Flores… - Vaccine, 2019‏ - Elsevier
Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide. Using the
data from the HERACLES clinical surveillance study (2007–2016), we describe the …

Complicated pneumonia in children

R Pabary, IM Balfour-Lynn - Breathe, 2013‏ - publications.ersnet.org
Educational aims To understand the pathogenesis of complicated community-acquired
pneumonia in children To gain an understanding into the management of common …

Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy

S Esposito, A Marchese, AE Tozzi… - The Pediatric …, 2012‏ - journals.lww.com
Background: This study was designed to determine the proportion of bacteremic
pneumococcal cases in a group of pediatric subjects with community-acquired pneumonia …

Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children

J Ruiz-Contreras, J Picazo, J Casado-Flores… - Vaccine, 2017‏ - Elsevier
Objectives To evaluate the impact of 13-valent pneumococcal conjugate vaccine on
pneumococcal meningitis in children. Methods Children younger than 15 years of age …